´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ SISSO2024 (Seoul International Symposium of Surgical Oncology 2024)(1ÀÏÂ÷) : 2024-02-23
±³À°ÀÏÀÚ : 2024-02-23
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿ÈúÈ£ÅÚ ºñ½ºÅ¸È¦
±³À°ÁÖÁ¦ : SISSO2024 (Seoul International Symposium of Surgical Oncology 2024)(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ
´ã´çÀÚ : ¼¿µ¾Ö
¿¬¶ôó : 02-393-2114
À̸ÞÀÏ : ksco2004 @daum.net
±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 11 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 220,000¿ø
ºñ°í "µî·ÏºñDoctor Member KRW 150,000 KRW 170,000Non-member KRW 180,000 KRW 200,000Exhibitor KRW 200,000 KRW 220,000Resident / Student / Nurse / KSSO Member of Age 65 or Over Free"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 09:00~09:20 Enhancing transparency and reproducibility in gastric cancer surgical trials: Strategies from enrollment to reporting Ziyu Li(Peking University Hospital, China)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 09:20~09:40 Colorectal cancer ¹ÚÁö¿ø(¼¿ïÀÇ´ë )
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 09:40~10:00 Personal experience of conducting randomized clinical trail; ASTRRA study ±èÇö¾Æ(¿øÀڷº´¿ø)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:00~09:10 (±¸¿¬)Intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis – updated safety and efficacy from the IPLUS phase I/II trial °¼ÒÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:10~09:20 (±¸¿¬)Reevaluation of the predictors for lymph node metastasis and residual tumor in T1 colorectal cancer Weilin Liao(Guangdong Provincial Hospital of Traditional Chinese Medicine, China)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:20~09:30 (±¸¿¬)Solid lipid nanoparticle ganodric acid ameliorates the high fat induced nonalcoholic fatty liver disease via alteration gut microbiota and PI3K/AKT/mTOR signaling pathway D Chauhan(RK Science Management College, India)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:30~09:40 (±¸¿¬)Stage-matched prognosis comparison between ypTNM and pTNM stage in pancreatic cancer ±èÇü¼®(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:40~09:50 (±¸¿¬)Microsphere-based paclitaxel long-acting injectable (LAI) demonstrates potential for the treatment of pancreatic cancer ±èÀαÔ(G2GBIO)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 09:50~10:00 (±¸¿¬)The role of microbiome influencing Ki67 expression in patients with breast cancer ¾ÈÁ¤½Å(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 10:00~10:30 Updates of breast cancer treatment and research Kelly K. Hunt(MD Anderson Cancer Center, USA)
ÈÞ½Ä 02¿ù 23ÀÏ Room 1, 2 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 10:50~11:05 Gastric cancer Jimmy So(National University of Singapore, Singapore)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 11:05~11:20 Pancreatic cancer È«½Â¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 11:20~11:35 Gallbladder cancer ±èÈ«¹ü(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 11:35~11:50 Harmonizing guidelines and practice: innovations and realities in colorectal cancer care ¿ÀÈï±Ç(¼¿ïÀÇ´ë)
Åä·Ð 02¿ù 23ÀÏ Room 1 11:50~12:00 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 10:50~11:05 The process of materializing commercialized ideas from medical needs Peter Kim(Activ Surgical / The George Washington University, USA)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 11:05~11:20 How to be familiar with single cell RNA sequencing analysis as a surgical oncologist À̽ÂÈ£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 11:20~11:35 Implementation of minimal invasive surgery for surgical oncology in Philippines Rene Ronson Ang(Cardinal Santos Medical Center, Philippines)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 11:35~11:50 Harsh reality of being a surgical oncologist new to chemotherapy practice ±èµ¿¿í(´Ü±¹ÀÇ´ë)
Åä·Ð 02¿ù 23ÀÏ Room 1 11:50~12:00 Discussion ()
ÈÞ½Ä 02¿ù 23ÀÏ Room 1 12:00~13:00 Bleeding control after hepatectomy Á¶À翵(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 13:00~13:15 Medical Oncologist ±Ç¹Î¼®(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 13:15~13:30 Surgical Oncologist ±è³ª·ç(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 13:30~13:45 Medical Oncologist ±èÇüµ·(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 13:45~14:00 Surgical Oncologist Masanori Terashima(Shizuoka Cancer Center, Japan)
Åä·Ð 02¿ù 23ÀÏ Room 1 14:00~14:10 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 13:00~13:20 Heterogeneity of immune cells in solid tumor ÀÌ¿ëÁØ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 13:20~13:40 Single-cell sequencing to determine the immune landscape of colorectal cancer ¹Ú¿õ¾ç(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 13:40~14:00 Spatial multi-omics analyses of the tumor immune microenvironment À̼ºÈ¯(Â÷ÀÇ´ë)
Åä·Ð 02¿ù 23ÀÏ Room 2 14:00~14:10 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 14:10~14:40 Pancreas cancer: The dawning of a new era Jeffrey Drebin(Memorial Sloan Kettering Cancer Center, USA)
ÈÞ½Ä 02¿ù 23ÀÏ Room 1, 2 14:40~15:00 Coffee Break ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 15:00~15:20 Artificial intelligence in cancer diagnosis ±èÈÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 15:20~15:40 Digital healthcare in the treatment of cancer patients Anthony D Yang(Indiana University, USA)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 15:40~16:00 Patient-customized digital healthcare system after treatment ³²º´È£(¢ßÇ층½º)
Åä·Ð 02¿ù 23ÀÏ Room 1 16:00~16:10 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 15:00~15:20 The 1st experience of KSSO clinical trial: KSSO-1 ¼Õ°æ¸ð(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 15:20~15:30 (¿¬±¸¹ßÇ¥)Laparoscopic hyperthermic intraperitoneal chemotherapy (LHIPEC) and neoadjuvant intraperitoneal-systemic chemotherapy (NIPS) for gastric cancer with peritoneal metastasis °¼ÒÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 15:30~15:40 (¿¬±¸¹ßÇ¥)Exploration of the frequency and clinico-pathologic-molecular characteristics of lynch syndrome in Korean MSI-H gastric cancer ¼Û±ÝÁ¾(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 15:40~15:50 (¿¬±¸¹ßÇ¥)Development of comprehensive treatment response assessment index to neoadjuvant chemoradiotherapy for rectal cancer using integrative analysis of medical image and liquid biopsy ¹ÚÀÎÀÚ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 15:50~16:10 Nurse °ÇýÀÎ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 2 16:10~16:30 How to manage cancer patients in the community ¹ÚÀº¿µ(°¡Ãµ´ëÇб³)
Åä·Ð 02¿ù 23ÀÏ Room 2 16:30~16:40 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 16:10~16:25 Re resection À¯¿µµ¿(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 16:25~16:40 Wait and see or additional chemo, RT À̽ÂÀº(Áß¾ÓÀÇ´ë)
Åä·Ð 02¿ù 23ÀÏ Room 1 16:40~16:45 Discussion ()
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 16:45~17:00 Front surgery ÀÌâ¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02¿ù 23ÀÏ Room 1 17:00~17:15 Neoadjuvant or conversion surgery ¾ÈÇý¼º(¼¿ïÀÇ´ë)
Åä·Ð 02¿ù 23ÀÏ Room 1 17:15~17:20 Discussion ()